tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Posts Tagged 'Cell Encapsulation'

Nuvilex, Inc.’s Phase III Pancreatic Cancer Trials Could Address New Law’s Call for Progress

Nuvilex, Inc.’s Phase III Pancreatic Cancer Trials Could Address New Law’s Call for Progress

Written by ι Stock Market Media Group Staff — June 24, 2013

Nuvilex, Inc. (OTCQB: NVLX) has a great opportunity to demonstrate and showcase its encapsulation technology in its upcoming Phase III clinical trials for the treatment of late stage, inoperable pancreatic cancer.  There will be plenty of interested observers, and you can bet that those US Senators and Congressmen responsible for the Recalcitrant Cancer Research Act that was signed into law earlier this year, will be among them.

Nuvilex’s upcoming late stage ...

Read More →
0

Nuvilex, Inc.’s Cell Encapsulation Could Play Role in Multimodality Treatment of Cancer Patients

Nuvilex, Inc.’s Cell Encapsulation Could Play Role in Multimodality Treatment of Cancer Patients

Written by ι Stock Market Media Group Staff — June 6, 2013

Nuvilex, Inc. (OTCQB: NVLX) has a technology in its cell encapsulation process that will very likely play some role in the future of oncology.  How large that role will be is contingent upon the technology continuing to return solid results when it’s put to the test.  One such area where the technology has had a chance to prove its worth is in a preclinical study that was reported in the ...

Read More →
0

Nuvilex, Inc. Medical Marijuana Research May Enhance Its Diabetes Studies

Nuvilex, Inc. Medical Marijuana Research May Enhance Its Diabetes Studies

Written by ι Stock Market Media Group Staff — May 29, 2013

Nuvilex, Inc. (OTCQB: NVLX) and its medical marijuana subsidiary, Medical Marijuana Sciences, Inc., may have just found a way to work side by side in an area of study where the parent company is already engaged.  Nuvilex, an international biotechnology firm, has conducted a preclinical diabetes study where the company was able to use its cell encapsulation technology to essentially develop a type of “artificial pancreas” that controls blood sugar levels ...

Read More →
0

Nuvilex, Inc. Could Become Significant Player in the Oncology Arena with Successful Phase III Trials

Nuvilex, Inc. Could Become Significant Player in the Oncology Arena with Successful Phase III Trials

Written by ι Stock Market Media Group Staff — May 22, 2013

Nuvilex, Inc. (OTCQB NVLX) is a diamond in the rough in the truest sense.  Currently shares of the Silver Spring, Maryland, biotechnology firm can be purchased for around 0.15/share allowing investors to build an incredible position in the company for what could be a blockbuster future.  Don’t expect these great prices to last forever though.  According to Nuvilex’s COO, Dr. Gerry Crabtree, the company expects to start its pivotal Phase III ...

Read More →
0

Nuvilex, Inc. and Celgene Corp. Can Both Replace Eli Lilly’s Cancer Drug Gemzar

Nuvilex, Inc. and Celgene Corp. Can Both Replace Eli Lilly’s Cancer Drug Gemzar

Written by ι Stock Market Media Group Staff — May 20, 2013

The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner’s treatment.  Two biotechnology companies are registering impressive data in each of their own pancreatic cancer trials, so impressive in fact, Eli Lilly & Co. (NYSE: LLY) is surely feeling its long time reign as the current standard single-drug treatment for the disease being threatened.  Nuvilex, Inc. (OTCQB: NVLX) and Celgene Corp. (NASDAQ: ...

Read More →
0

Nuvilex, Inc. Cell Encapsulation Could Mimic Combination Chemotherapy

Nuvilex, Inc. Cell Encapsulation Could Mimic Combination Chemotherapy

Written by ι Stock Market Media Group Staff — May 15, 2013

Nuvilex, Inc. (OTCQB: NVLX) has had its living cell encapsulation or “Cell-in-a-Box” technology tested again and again, and each time it has proven it can do exactly what it’s intended to do.  To date, the proprietary technology has more than impressed and continuously returns remarkable data after each study.  In a study not yet discussed, “Cell-in-a-Box” was used to enclose cells that activate more than one anticancer drug simultaneously.  This is ...

Read More →
0
Page 5 of 7 «...34567
ContactUs.com